22 May 2013
Keywords: greater, commercialization, research, pipe-dream, david, tubby, marks
Article | 15 November 2004
The UK continues to falter in its ability to commercialize R&D. This has been recognized in the government's science ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 November 2004
22 November 2004
21 May 2013
© 2013 thepharmaletter.com